{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T17:16:01Z","timestamp":1765041361325,"version":"3.46.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["americanjournalofsurgery.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Surgery"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.amjsurg.2025.116709","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T16:30:08Z","timestamp":1762360208000},"page":"116709","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Impact of non-metropolitan residence on survival for gastric neuroendocrine tumors"],"prefix":"10.1016","volume":"251","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6510-5685","authenticated-orcid":false,"given":"Hilary R.","family":"Keller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas A.","family":"Hanes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jillian K.","family":"McCabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danny","family":"Lascano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie","family":"Goldfarb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.amjsurg.2025.116709_bib1","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-81518-4","article-title":"Epidemiology, treatment and outcomes of gastroenteropancreatic neuroendocrine neoplasms","volume":"14","author":"Uhlig","year":"2024","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.amjsurg.2025.116709_bib2","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.dld.2021.11.012","article-title":"Management of type-I gastric neuroendocrine neoplasms: a 10-years prospective single centre study","volume":"54","author":"Esposito","year":"2022","journal-title":"Dig Liver Dis"},{"issue":"11","key":"10.1016\/j.amjsurg.2025.116709_bib3","doi-asserted-by":"crossref","first-page":"4334","DOI":"10.1177\/00031348221109460","article-title":"Gastric neuroendocrine tumor treatment and survival outcome depends on facility type","volume":"89","author":"Platoff","year":"2023","journal-title":"Am Surg\u2122"},{"issue":"2","key":"10.1016\/j.amjsurg.2025.116709_bib4","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1590\/0102-6720201700020016","article-title":"Gastric neuroendocrine tumor: review and update","volume":"30","author":"Dias","year":"2017","journal-title":"ABCD Arquivos Brasileiros de Cirurgia Digestiva (S\u00e3o Paulo)"},{"key":"10.1016\/j.amjsurg.2025.116709_bib5","series-title":"Classification of Neuroendocrine Neoplasms of the Digestive System. WHO Classification of Tumours, 5th Edition","first-page":"16","author":"Klimstra","year":"2019"},{"issue":"4","key":"10.1016\/j.amjsurg.2025.116709_bib6","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/MPA.0b013e31828e34a4","article-title":"Consensus guidelines for the management and treatment of neuroendocrine tumors","volume":"42","author":"Kunz","year":"2013","journal-title":"Pancreas"},{"issue":"8","key":"10.1016\/j.amjsurg.2025.116709_bib7","doi-asserted-by":"crossref","DOI":"10.1530\/ERC-22-0206","article-title":"Expert consensus practice recommendations of the North American neuroendocrine tumor society for the management of high grade gastroenteropancreatic and gynecologic neuroendocrine neoplasms","volume":"30","author":"Eads","year":"2023","journal-title":"Endocr Relat Cancer"},{"issue":"3","key":"10.1016\/j.amjsurg.2025.116709_bib8","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/den.13778","article-title":"Is endoscopic resection appropriate for type 3 gastric neuroendocrine tumors? Retrospective multicenter study","volume":"33","author":"Hirasawa","year":"2021","journal-title":"Dig Endosc"},{"key":"10.1016\/j.amjsurg.2025.116709_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11894-019-0684-7","article-title":"Gastric neuroendocrine tumors (carcinoids)","volume":"21","author":"Gluckman","year":"2019","journal-title":"Curr Gastroenterol Rep"},{"issue":"7","key":"10.1016\/j.amjsurg.2025.116709_bib10","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1056\/NEJMoa2403991","article-title":"Phase 3 trial of cabozantinib to treat advanced neuroendocrine tumors","volume":"392","author":"Chan","year":"2025","journal-title":"N Engl J Med"},{"issue":"suppl ment","key":"10.1016\/j.amjsurg.2025.116709_bib11","article-title":"Management of advanced gastroenteropancreatic neuroendocrine tumors","volume":"23","author":"Bergsland","year":"2025","journal-title":"J Natl Compr Cancer Netw"},{"issue":"10","key":"10.1016\/j.amjsurg.2025.116709_bib12","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1001\/jamaoncol.2017.0589","article-title":"Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States","volume":"3","author":"Dasari","year":"2017","journal-title":"JAMA Oncol"},{"issue":"18","key":"10.1016\/j.amjsurg.2025.116709_bib13","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1200\/JCO.2007.15.4377","article-title":"One hundred years after \u201ccarcinoid\u201d: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States","volume":"26","author":"Yao","year":"2008","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.amjsurg.2025.116709_bib14","doi-asserted-by":"crossref","first-page":"R153","DOI":"10.1530\/ERC-13-0125","article-title":"Incidence of gastroenteropancreatic neuroendocrine tumours: a systematic review of the literature","volume":"21","author":"Fraenkel","year":"2014","journal-title":"Endocr Relat Cancer"},{"issue":"2","key":"10.1016\/j.amjsurg.2025.116709_bib15","doi-asserted-by":"crossref","first-page":"27","DOI":"10.6004\/jnccn.2024.7080","article-title":"Burdens of gastroenteropancreatic neuroendocrine neoplasm by diverse race and ethnicities\u2014A rigorous structural equation modeling","volume":"23","author":"Paciorek","year":"2025","journal-title":"J Natl Compr Cancer Netw"},{"issue":"10","key":"10.1016\/j.amjsurg.2025.116709_bib16","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1097\/MPA.0000000000001431","article-title":"Racial differences in the incidence and survival of patients with neuroendocrine tumors","volume":"48","author":"Shen","year":"2019","journal-title":"Pancreas"},{"issue":"9","key":"10.1016\/j.amjsurg.2025.116709_bib17","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.24750","article-title":"Epidemiologic trends of and factors associated with overall survival for patients with gastroenteropancreatic neuroendocrine tumors in the United States","volume":"4","author":"Xu","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"6","key":"10.1016\/j.amjsurg.2025.116709_bib18","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1002\/jso.25662","article-title":"Interaction of race and pathology for neuroendocrine tumors: epidemiology, natural history, or racial disparity?","volume":"120","author":"DePalo","year":"2019","journal-title":"J Surg Oncol"},{"issue":"4","key":"10.1016\/j.amjsurg.2025.116709_bib19","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/cncr.32607","article-title":"Geographic and demographic features of neuroendocrine tumors in the United States of America: a population-based study","volume":"126","author":"Gosain","year":"2020","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.amjsurg.2025.116709_bib20","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/MPA.0000000000001707","article-title":"Racial differences in gastroenteropancreatic neuroendocrine tumor treatment and survival in the United States","volume":"50","author":"Kessel","year":"2021","journal-title":"Pancreas"},{"issue":"5","key":"10.1016\/j.amjsurg.2025.116709_bib21","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.amjsurg.2021.08.030","article-title":"Presentation and survival of gastro-entero-pancreatic neuroendocrine tumors in young adults versus older patients","volume":"223","author":"Nguyen","year":"2022","journal-title":"Am J Surg"},{"issue":"8","key":"10.1016\/j.amjsurg.2025.116709_bib22","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1245\/s10434-017-5899-y","article-title":"Increased grade in neuroendocrine tumor metastases negatively impacts survival","volume":"24","author":"Keck","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.amjsurg.2025.116709_bib23","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s12022-022-09708-2","article-title":"Overview of the 2022 WHO classification of neuroendocrine neoplasms","volume":"33","author":"Rindi","year":"2022","journal-title":"Endocr Pathol"},{"issue":"6","key":"10.1016\/j.amjsurg.2025.116709_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00268-014-2451-0","article-title":"Role of Ki-67 proliferation index in the assessment of patients with neuroendocrine neoplasias regarding the stage of disease","volume":"38","author":"Miller","year":"2014","journal-title":"World J Surg"},{"issue":"2","key":"10.1016\/j.amjsurg.2025.116709_bib25","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/cncr.23549","article-title":"Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors","volume":"113","author":"Pape","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.amjsurg.2025.116709_bib26","series-title":"Gastroenteropancreatic Neuroendocrine Tumors. the American Cancer Society's Oncology in Practice","first-page":"552","author":"Strosberg","year":"2018"}],"container-title":["The American Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000296102500532X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000296102500532X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T17:08:33Z","timestamp":1765040913000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000296102500532X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":26,"alternative-id":["S000296102500532X"],"URL":"https:\/\/doi.org\/10.1016\/j.amjsurg.2025.116709","relation":{},"ISSN":["0002-9610"],"issn-type":[{"type":"print","value":"0002-9610"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of non-metropolitan residence on survival for gastric neuroendocrine tumors","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjsurg.2025.116709","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116709"}}